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Background: The aim of the present study was to introduce a new restricted tangential volumetric modulated arc
therapy (tVMAT) technique for whole breast irradiation and compare its dosimetric properties to other currently
used breast cancer radiotherapy techniques.
Method: Ten consecutive women with left-sided breast cancer were enrolled in this retrospective study. Four
treatment plans were generated for each patient: 1) standard tangential field-in-field (FinF), 2) tangential intensity
modulated radiotherapy (tIMRT), 3) tangential VMAT (tVMAT) with two dual arcs of 50-60° and 4) continuous VMAT
(cVMAT) with a dual arc of 240°. The plans were created with Monaco® (tIMRT, tVMAT and cVMAT) and Oncentra®
(FinF) treatment planning systems.
Results: With both VMAT techniques significantly higher cardiac avoidance, dose coverage and dose homogenity
were achieved when compared with FinF or tIMRT techniques (p < 0.01). VMAT techniques also decreased the high
dose areas (above 20 Gy) of ipsilateral lung. There were no significant differences in the mean dose of contralateral
breast between the tVMAT, tIMRT and FinF techniques. The dose coverage (V47.5 Gy) was greatest with cVMAT.
However, with cVMAT the increase of contralateral breast dose was significant.
Conclusions: The present results support the hypothesis that the introduced tVMAT technique is feasible for
treatment of left-sided breast cancer. With tVMAT dose to heart and ipsilateral lung can be reduced and the dose
homogeneity can be improved without increasing the dose to contralateral breast or lung.
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Adjuvant radiotherapy (RT) after breast-conserving sur-
gery of breast cancer decreases the rate of recurrence
and increases the overall survival [1]. Unfortunately, a
number of patients develop radiation related complica-
tions such as breast fibrosis, changes in the breast ap-
pearance and late pulmonary and cardiovascular
complications [2-4]. Although the frequency of radiation-
induced complications has decreased along the develop-
ment of RT techniques, novel methods are needed for
effective reduction of dose to heart and ipsilateral lung.
Dose inhomogeneity in treated breast has been
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unless otherwise stated.induced toxicities such as fibrosis, erythema, moist
desquamation and oedema [5]. With conventional tan-
gential field-in-field (FinF) or wedge field techniques the
dose inhomogeneities are usually unavoidable, especially
in large-breasted patients. Furthermore, the increased
use of hypofractionation has also increased the require-
ment for the dose homogeneity in breast cancer RT [6].
Simultaneously, to avoid radiation induced pulmonary
complications dose volume constraints for ipsilateral
lung must also be employed [5,7]. In addition to pul-
monary complications, more and more concern has
been addressed on cardiac mortality related to left-sided
whole breast irradiation (WBI) [1,4]. Furthermore, spar-
ing of left anterior descending coronary artery (LAD)
has been recommended to avoid late coronary complica-
tions [8]. Since recommendations on safe dose levels tohis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cardiac exposure are needed [9].
Static tangential field or intensity modulated radiother-
apy (IMRT) techniques are generally used for WBI. Tan-
gential field techniques usually consist of two opposing
fields and the dose intensity modulation is limited from
these directions. As a consequence the avoidance of
heart and ipsilateral lung might lead to compromising
the target volume coverage and also result in higher
dose inhomogeneities. IMRT has been shown to improve
target dose coverage and minimize the dose in organs at
risk [10,11]. However, IMRT techniques with multiple
treatment fields have been reported to increase the low
dose volumes in contra- and ipsilateral lung and contra-
lateral breast [12,13]. Consequently, a fear of increasing
the risk for second cancer has hindered the use of IMRT
techniques in WBI.
Volumetric modulated arc therapy (VMAT) is a rela-
tively new technique based on simultaneous optimization
of multi leaf collimator (MLC), gantry rotation and dose
rate. So far the VMAT techniques have been applied for
WBI with varying results [14-16]. When compared to
IMRT greater target volume coverage and homogeneity
have been achieved with VMAT. In addition, VMAT has
reduced ipsilateral lung doses when compared to conven-
tional tangential field techniques [15]. However, the earlier
VMAT techniques have been reported to increase the
mean dose of contralateral lung, contralateral breast and
heart as compared to the tangential techniques. Thus it
has been concluded that the studied VMAT techniques
should not be used for WBI [14]. In the previous dosimet-
ric studies full or continuous partial arcs have been used
in VMAT treatment planning [14-16]. Analogous to
multiple-field IMRT plans, the use of full arcs conse-
quently increases the irradiated volume. The aim of the
present study was to introduce and dosimetrically evaluate
a restricted tangential VMAT technique for left-sided
breast cancer. We hypothesize that with the proposed tan-
gential VMAT (tVMAT) technique the dose homogeneity
within target volume can be increased. Furthermore, we
hypothesize that radiation dose to heart and lung can be
decreased without increasing low dose volume, especially




Ten patients (age 65 ± 6 years) with left-sided breast
cancer without nodal involvement were selected in this
retrospective study. The study was approved by the Re-
search Ethics Committee of Northern Savo Hospital
District. The patients were imaged with a CT scanner
(Toshiba Aquilion LB, Toshiba Medical Systems Co.,
Tochigi, Japan) in treatment position (supine, arms up).CT images were acquired from the level of mandible to
the basis of lungs with a slice thickness of 2 mm.
Target and OAR delineation
The delineation of the clinical target volume (CTV) was
based on the RTOG guidelines (http://www.rtog.org/
corelab/contouringatlases.aspx). A margin of 5 mm was
added to the CTV resulting in the planning target vol-
ume (PTV). The volumes outside the body contour and
inside the lung were excluded from the PTV. Further-
more, for the plan evaluation and normalization pur-
poses, a margin of 5 mm from skin surface was
excluded from the PTV (resulting PTVin). PTVin was
also used as a target volume in the optimization of
VMAT and IMRT plans to avoid overdosing the skin.
Organs at risks (OAR) defined in this study were
contra- and ipsilateral lung, heart, LAD, contralateral
breast and normal tissue which was defined by exclud-
ing the PTV from the body surface (Body-PTV).
Dose objectives and constraints
The prescription dose was 50 Gy in 25 fractions. The
primary aim in treatment planning was to achieve 98%
dose coverage of 47.5 Gy (V47.5) in the PTV. VMAT
and IMRT plans were optimized in Monaco® TPS in a
constrained mode and biological cost functions were
used as constraints. The volumes of doses 30 Gy, 25 Gy
and 2 Gy (V30, V20, V2) were minimized for heart and
LAD. For ipsilateral lung volumes of doses 20 Gy, 10 Gy
and 5 Gy (V20, V10 and V5) were minimized. For contra-
lateral lung and breast the doses were optimized to be
less than 5 and 2 Gy, respectively. The objective functions
were specified individually for each patient to accomplish
the best achievable treatment plan. For FinF plans the
treatment planning goal was to achieve the same dose
objectives used in the IMRT and VMAT planning.
Treatment planning
Treatment plans were created for Elekta Infinity® accel-
erator (Elekta AB, Stockholm, Sweden) with 5 mm Agil-
ity® MLC. The treatment energies (either 6 or 10 MV)
were selected according to the size of the PTV. Four
separate treatment plans with an identical isocenter
were created to each patient as shown in Figure 1: 1) a
standard tangential FinF, 2) a dynamic IMRT with two
static tangential fields (tIMRT), 3) tangential VMAT
(tVMAT) with two tangential dual arcs of 50-60° and
4) continuous VMAT (cVMAT) treatment plan with one
dual arc of 240°. The tVMAT, cVMAT and tIMRT plans
were generated using Monaco® treatment planning
system (TPS) (version 3.30.01, Elekta AB). To determine
optimal arc configuration for tVMAT and cVMAT plans
several plans with different plan parameter (e.g. start and
stop angles of the arcs) were generated and beam
Figure 1 Typical beam arrangements for FinF (A), tIMRT (B), tVMAT (C) and cVMAT (D).
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to the study. Surface margin (e.g. the inner margin from
skin surface that is excluded from the optimization) was
set to 0.5 cm. Minimum segment width of 1.0 cm and
high fluence smoothing was used in the optimization. To
avoid under dosing the skin optimized radiation fluences
were extended 2 cm outside the body surface using auto
flash operation available in Monaco® TPS. Maximum
number of control points per plan was set to 170. A
standard deviation of 0.5% was used in Monte Carlo
(MC) dose calculation with a dose grid of 3.0 mm. The
3D-CRT FinF plans were generated in Oncentra® TPS
(version 4.3.0.410, Elekta AB) with collapsed cone convo-
lution (CCC) dose calculation algorithm with a dose grid
of 3.0 mm. Doses to the OARs were minimized without
compromising the PTV coverage as recommended by
QUANTEC [17]. All treatment plans were normalized to
the mean dose of PTVin.
Plan analysis
Dose volume histograms (DVH) of the treatment plans
were used in analyzing target coverage and doses to the
OAR’s. In addition, the plan qualities were compared
by the homogeneity index (HI) and conformity index
(CI). The plan CI, defined by Paddick [18], is given by
CI ¼ TVPIV
2
TV ⋅PIVð Þ ;
where the TVPIV is the volume of the PTVin covered by
the prescription isodose, TV is the volume of the PTVinand PIV the total volume covered by the prescription
isodose. The HI was defined as
HI ¼ D1 −D98ð Þ
DP
;
where D1 is the minimum dose in 1% of the PTVin, D98
is the minimum dose in 98% of the PTVin and DP is the
prescription dose.
Statistical analysis
One way analysis of variance with least significant
difference post-hoc test (LSD) was conducted using
SPSS software (version 19.0.0.2, IBM, USA) to evalu-
ate the significance of difference between the dosi-
metric parameters calculated from the treatment
plans. A p-value <0.05 was considered significant.
Results
The VMAT and the IMRT techniques achieved signifi-
cantly higher dose homogeneity (lower HI-value, p < 0.01)
when compared with the FinF technique (Table 1). Fur-
thermore, with the both VMAT techniques the dose
homogeneity was significantly higher as compared to
tIMRT (p < 0.05). No significant difference in CI was de-
tected between the VMAT, IMRT or FinF techniques.
The dose coverage (V47.5 Gy) was significantly superior
with VMAT techniques as compared with FinF and
tIMRT techniques (p < 0.05). There was no statistical dif-
ference in V47.5, HI or CI between tVMAT and cVMAT
techniques.
Table 1 Mean values and standard deviations (n = 10) of the dosimetric parameters for the different techniques
studied
tVMAT cVMAT tIMRT FinF
PTV
D1cm3 (Gy) 53.4 ± 0.5 53.3 ± 0.4 53.7 ± 0.5 53.5 ± 0.6
V47.5 (%) 97.8 ± 0.8 98.1 ± 1.0 96.3 ± 2.0 91.4 ± 2.4
HI 0.10 ± 0.01 0.10 ± 0.01 0.12 ± 0.02 0.14 ± 0.01
CI 0.50 ± 0.03 0.50 ± 0.04 0.45 ± 0.05 0.47 ± 0.09
Lung, Ipsilateral
V20 (%) 18.1 ± 5.3 15.3 ± 4.6 21.6 ± 4.0 21.4 ± 3.7
V10 (%) 25.3 ± 5.6 23.4 ± 5.6 26.2 ± 4.3 25.7 ± 3.8
V5 (%) 36.9 ± 5.4 35.5 ± 5.6 33.3 ± 4.3 32.0 ± 3.6
Mean dose (Gy) 9.6 ± 2.1 8.7 ± 1.7 10.9 ± 1.8 10.4 ± 1.5
Lung, Contralateral
Mean dose (Gy) 0.9 ± 0.1 1.6 ± 0.7 0.7 ± 0.1 0.7 ± 0.1
Heart
V30 (%) 5.7 ± 6.0 3.4 ± 3.9 13.9 ± 6.8 15.2 ± 6.9
V25 (%) 8.2 ± 6.9 5.0 ± 5.3 15.4 ± 7.1 16.4 ± 7.4
V2 (%) 60.8 ± 18.8 68.4 ± 22.3 61.3 ± 14.4 57.9 ± 14.4
Mean dose (Gy) 6.3 ± 3.0 5.5 ± 2.9 9.1 ± 3.4 9.1 ± 3.5
LAD
V30 (%) 43.1 ± 29.5 32.0 ± 27.3 67.8 ± 19.9 79.7 ± 8.1
V25 (%) 55.0 ± 27.8 40.3 ± 28.4 72.2 ± 15.1 81.2 ± 7.5
Mean dose (Gy) 24.3 ± 8.0 20.4 ± 8.7 34.4 ± 7.0 37.9 ± 3.6
Breast, Contralateral
V2 (%) 10.2 ± 7.0 53.0 ± 27.1 11.1 ± 5.6 7.0 ± 4.8
Mean dose (Gy) 1.2 ± 0.3 2.6 ± 1.2 1.0 ± 0.4 1.0 ± 0.3
Normal tissue (Body-PTV)
V53.5 (cm3) 0.9 ± 1.1 0.4 ± 0. 5 8.5 ± 15.6 1.9 ± 4.1
V2 (%) 20.3 ± 4.6 30.4 ± 8.3 17.3 ± 2.8 15.9 ± 3.4
Mean dose (Gy) 3.3 ± 0.5 3.8 ± 0.6 3.3 ± 0.5 3.4 ± 1.1
Body
Integral Dose (Gydm3) 105.3 ± 43.4 113.5 ± 43.8 105.6 ± 43.8 99.3 ± 46.5
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achieved with VMAT techniques when compared to
FinF or tIMRT (Table 1, Figure 2, Figure 3). With
tVMAT and cVMAT the V30 and V25 volumes to the
heart and LAD were significantly lower when compared
to IMRT or FinF techniques (p < 0.05) (Table 1). Fur-
thermore, the cVMAT technique reduced the mean dose
of the heart significantly when compared with tIMRT or
FinF (p < 0.05). Slight but non-significant reduction of
V2 of the heart was achieved with FinF as compared
with that of tVMAT, cVMAT or tIMRT.
Significant decrease in high dose volume (V20) and
mean dose of ipsilateral lung was achieved with
cVMAT technique as compared with tIMRT or FinF
plans (p < 0.01) (Table 1). Additionally, with tVMATtechnique the reduction of high dose volume to the
lung was evident as compared with tIMRT and FinF
(Figure 2, Figure 3). However, no statistically signifi-
cant differences were found in V20, V10 or V5 vol-
umes between tVMAT, tIMRT or FinF techniques.
cVMAT increased the mean dose of the contralateral
lung significantly when compared with other tech-
niques (p < 0.01). The difference was non-significant
between tVMAT, tIMRT and FinF.
The difference in contralateral breast mean dose be-
tween tVMAT, tIMRT and FinF techniques was non-
significant (Table 1, Figure 3). However, the cVMAT
technique increased the mean dose of contralateral
breast significantly (p < 0.01). No significant differences
were detected in the low dose volumes (V2) to normal
Figure 2 Average cumulative DVHs (n = 10) for the four different techniques studied. PTVin (A), contralateral breast (B), left anterior
descending coronary artery (C), heart (D), ipsilateral lung (E), and contralateral lung (F).
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techniques as with cVMAT the increase was significant
(p < 0.01, Table 1). No significant differences in meandose to the normal structures or integral doses to body
were detected between the techniques (Table 1). The
average number of monitor units (MUs) with one
Figure 3 Typical dose distributions for one patient planed with (A) FinF, (B) tIMRT, (C) tVMAT and (D) cVMAT techniques.
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283 ± 37 MU and 233 ± 5 MU with tVMAT, cVMAT,
tIMRT and FinF, respectively.
Discussion
In this dosimetric study two different VMAT techniques
were investigated for left-sided breast cancer radiother-
apy and were found to increase the dose homogeneity
when compared with tIMRT and FinF. Similarly, signifi-
cant increases in dose homogeneity and coverage have
been reported as IMRT or VMAT techniques have been
compared with conventional techniques [13,14,19]. Cor-
respondingly with the previous studies high doses to
heart and LAD was avoided with the studied VMAT
techniques [14,20]. As the mean dose and doses of 25
and 30 Gy to heart have been reported to be detrimental
[4,17,21], it would support the potential of VMAT tech-
niques in WBI.
In this study the high dose volumes in ipsilateral lung
were decreased by using the VMAT techniques. Similar
results have also been reported in previous studies in
which VMAT or IMRT techniques have been compared
with conventional tangential techniques [11,15,16].
However, when using the VMAT or IMRT techniques
without restricting the field directions (as with cVMAT)
significant increase in low dose volume has also been
observed. Fear of increasing the low dose volume to
lungs and contralateral breast is probably the main rea-
son for the delayed clinical implementation of IMRT and
VMAT techniques in WBI. As expected, increase in low
dose volume (V5 and V2) of lungs and contralateral
breast was detected with cVMAT plans when comparedto tVMAT, tIMRT or FinF. Since the IMRT fields in this
study were limited to opposing tangential directions no
significant differences were found in contralateral lung
or breast doses between tIMRT and FinF techniques.
Importantly, no significant differences in mean doses to
contralateral lung, and breast were detected between
tVMAT and conventional tangential techniques. Fur-
thermore, no significant differences were detected in
integral dose or mean dose to normal tissue between
the techniques. This indicates that there is no apparent
elevation in the second cancer risk related to tVMAT
technique.
Generally, mean doses to the heart, contralateral lung
and breast reported in the present study are higher than
those reported in some of the previous studies [11,14].
The main reason for this is the target delineation proto-
col used. In the current study the CTVs were delineated
strictly based on the RTOG guidelines resulting in sig-
nificantly larger target volumes (mainly to the medial
direction) than we would have used clinically. However,
an important conclusion from this study is that both the
studied VMAT techniques decreased the heart doses
when compared to conventional tangential techniques.
One of the limitations of this study is that the possible
movement of the breast during the treatment was not
accounted for. However, in recent dosimetric study no
significant differences were detected in the dose homo-
geneity between IMRT and tangential plans using a mov-
ing target [22]. In addition, the VMAT treatment plans
in this study were optimized with low beam modulation
avoiding sharp dose gradients inside the target volume
thus minimizing the effect of breathing motion to the
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different dose calculation algorithms (CCC and MC)
where used in the present study, part of the differences
in the low dose areas might result from the accuracy of
the used algorithms [23]. However, the dose distribu-
tions between the VMAT and IMRT treatment plans are
directly comparable, since they were planned and calcu-
lated with the same TPS with the same dose calculation
algorithm.
In the present study patients were treated in supine
position. To reduce the dose to ipsilateral lung and
heart, and to increase the dose homogeneity in PTV
prone treatment position has been proposed for patients
with large or pendulous breasts [24]. In the recent stud-
ies, in which prone treatment position was compared
with supine position, significant decrease in ipsilateral
lung dose was reported [25,26]. However, no significant
differences were detected in doses to heart between the
treatment positions [25,26]. As the heart typically moves
towards chest wall in prone position usage of VMAT
techniques to decrease the dose to heart might be bene-
ficial also in prone position. However, further studies are
needed to evaluate the potential of VMAT techniques in
prone treatment position.
To further avoid the irradiation of heart deep-
inspiration breath-hold techniques have been imple-
mented and introduced for WBI [27]. The use of VMAT
techniques could even further decrease the doses to car-
diac tissue and ipsilateral lung in deep-inspiration
breath-hold treatments. Unfortunately, there are a num-
ber of patients that cannot hold their breath for long
times or are having difficulties to manage the breath-
hold techniques. For those patients the VMAT
techniques should definitely be considered to avoid ir-
radiating high doses to heart. However, it should be
noted that even if large heart doses are avoided by using
breath-hold techniques significant increase in the dose
coverage and homogeneity can be achieved with VMAT.
The increase in dose homogeneity not only decreases
the possibility of developing adverse effects in breast tis-
sue but also allows the use of hypofractionation even for
the patients with a large PTV. It should also be noted
that with the restricted tVMAT technique the low dose
volume is not increased in contralateral breast.
Conclusion
The restricted tVMAT technique is an effective method
for achieving a homogeneous dose coverage simultan-
eously reducing doses to heart, LAD and ipsilateral lung.
Although, the cVMAT technique achieved the highest
reduction of high dose volume in heart, LAD and ipsilat-
eral lung, it also increased the low dose volumes of lung
and contralateral breast. Since the tVMAT technique
does not increase the low dose volumes in thecontralateral breast or lung and significantly increases
the dose coverage and homogeneity, the tVMAT tech-
nique could be a potential option for conventional WBI
techniques. However, further studies evaluating the clin-
ical outcome of treatments given with tVMAT technique
is needed to proof the clinical value of the technique. All
patients included in the present study were treated with
tVMAT technique.
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